Cottonseed oil alleviates ischemic stroke injury by inhibiting ferroptosis.

68Ga-citrate cottonseed oil (CSO) ferroptosis ischemic stroke neuroprotection positron emission tomography (PET)

Journal

Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837

Informations de publication

Date de publication:
Oct 2023
Historique:
revised: 09 07 2023
received: 30 03 2023
accepted: 12 07 2023
pubmed: 22 7 2023
medline: 22 7 2023
entrez: 21 7 2023
Statut: ppublish

Résumé

Ferroptosis has recently been recognized as a new cause of ischemia reperfusion injury due to blood-brain barrier (BBB) disruption followed by secondary iron-loaded transferrin (TF) influx. As a novel and independent cell death pathway, ferroptosis was characterized by iron-dependent lipid peroxidation, decline of GSH, GPX4, and shrinking mitochondria. Cottonseed oil (CSO), a liposoluble solvent, can alleviate ischemia stroke injuries and oxidative stress. However, the effect of CSO on ischemic stroke-induced ferroptosis has not been explored. In this study, we investigated the effect of CSO on ferroptosis caused by cerebral ischemic injury in rats. We conducted the subcutaneous injection of 1.3 mL/kg CSO every other day for 3 weeks on rats with middle cerebral artery occlusion-reperfusion (MCAO-R) injury. We used Garcia Test, TTC staining, HE, Nissl and NeuN staining, Evans blue test, CSO treatment could significantly ameliorate MCAO-R-induced neurological dysfunction in a male rat model. Furthermore, it reduced infarct volume and neuronal injuries; protected BBB integrity; reduced the influx of iron ion, TF, and TF receptors; up-regulated anti-ferroptosis proteins (GPX4, xCT, HO1, FTH1), while down-regulating ferroptosis-related protein ACSL4; increased the activity of GSH and SOD; and decreased MDA and LPO levels. Mitochondrial destruction induced by ischemic stroke was also alleviated by CSO treatment. CSO treatment can alleviate ischemic stroke injury via ferroptosis inhibition, which provides a new potential therapeutic mechanism for CSO neuroprotection against ischemic stroke.

Identifiants

pubmed: 37480159
doi: 10.1002/brb3.3179
pmc: PMC10570467
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3179

Subventions

Organisme : National Natural Science Foundation of China
ID : 82171464
Organisme : National Natural Science Foundation of China
ID : 82171180
Organisme : National Natural Science Foundation of China
ID : 81901097
Organisme : Capital Health Research and Development of Special Fund
ID : 2022-4-5025

Informations de copyright

© 2023 The Authors. Brain and Behavior published by Wiley Periodicals LLC.

Références

Science. 1976 Jun 11;192(4244):1139-41
pubmed: 1273587
Cell. 2019 May 16;177(5):1262-1279.e25
pubmed: 31056284
Redox Biol. 2021 May;41:101947
pubmed: 33774476
Nat Chem Biol. 2017 Jan;13(1):91-98
pubmed: 27842070
Mol Imaging Biol. 2016 Dec;18(6):946-951
pubmed: 27184068
Nat Rev Dis Primers. 2019 Oct 10;5(1):70
pubmed: 31601801
Lancet. 2012 Jun 23;379(9834):2352-63
pubmed: 22632908
Theranostics. 2021 Sep 13;11(19):9492-9502
pubmed: 34646382
BJU Int. 2011 Jul;108(2 Pt 2):E10-6
pubmed: 20875090
Front Cell Dev Biol. 2020 Jul 15;8:594
pubmed: 32760721
Ageing Res Rev. 2017 Mar;34:77-87
pubmed: 27697546
Oxid Med Cell Longev. 2021 Jun 25;2021:9991001
pubmed: 34257829
Mol Neurobiol. 2021 Jun;58(6):2494-2507
pubmed: 33443681
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970
J Neuroinflammation. 2020 Sep 11;17(1):270
pubmed: 32917229
Aging (Albany NY). 2020 Jun 29;12(13):12943-12959
pubmed: 32601262
Biosci Biotechnol Biochem. 2022 May 24;86(6):704-716
pubmed: 35357412
FEBS Lett. 2007 May 29;581(13):2541-8
pubmed: 17499720
Biol Rev Camb Philos Soc. 2019 Oct;94(5):1672-1684
pubmed: 31190441
BMJ. 2020 Feb 13;368:l6983
pubmed: 32054610
JAMA Neurol. 2013 Mar 1;70(3):353-8
pubmed: 23599933
Front Neurol. 2021 Mar 08;12:619043
pubmed: 33763013
Front Cell Neurosci. 2021 Apr 06;15:632354
pubmed: 33889074
Cell. 2015 Oct 22;163(3):560-9
pubmed: 26496603
Curr Pharm Des. 2018;24(7):787-794
pubmed: 29189131
Poult Sci. 2019 Sep 1;98(9):3860-3869
pubmed: 30877746
JCI Insight. 2018 Nov 2;3(21):
pubmed: 30385712
J Med Food. 2019 Jul;22(7):672-679
pubmed: 31112045
Neurotherapeutics. 2020 Oct;17(4):1796-1812
pubmed: 32959272
Nature. 2021 May;593(7860):586-590
pubmed: 33981038
J Neurol Sci. 2016 May 15;364:136-40
pubmed: 27084232
J Nucl Med. 2010 Dec;51(12):1932-6
pubmed: 21078801
Brain Behav. 2023 Oct;13(10):e3179
pubmed: 37480159

Auteurs

Miao Sun (M)

Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Department of Anesthesiology, The First Affiliated Hospital, Jinzhou Medical University, Jinzhou, Liaoning Province, China.

Min Liu (M)

Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Qingxiao Li (Q)

Department of Nuclear Medicine, The First Medical Center of Chinese PLA General Hospital, Beijing, China.

Xiaoying Zhang (X)

Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.

Siyuan Liu (S)

Department of Anesthesiology, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.

Huikai Yang (H)

Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.

Le Yang (L)

Department of Pharmacy, Tangdu Hospital, Air Force Military Medical University, Xi'an, Shaanxi Province, China.

Jiahe Tian (J)

Department of Nuclear Medicine, The First Medical Center of Chinese PLA General Hospital, Beijing, China.

Weidong Mi (W)

Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.

Yulong Ma (Y)

Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.

Classifications MeSH